Current and Future Biomarkers in Multiple Sclerosis

Multiple sclerosis (MS) is a debilitating autoimmune disorder. Currently, there is a lack of effective treatment for the progressive form of MS, partly due to insensitive readout for neurodegeneration. The recent development of sensitive assays for neurofilament light chain (NfL) has made it a poten...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jennifer, Hamade, Maysa, Wu, Qi, Wang, Qin, Axtell, Robert, Giri, Shailendra, Mao-Draayer, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180348/
https://www.ncbi.nlm.nih.gov/pubmed/35682558
http://dx.doi.org/10.3390/ijms23115877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180348/
https://www.ncbi.nlm.nih.gov/pubmed/35682558
http://dx.doi.org/10.3390/ijms23115877

Ejemplares similares